Cargando…
Current diagnosis and management of Crohn’s disease in China: results from a multicenter prospective disease registry
BACKGROUND: This study aimed to understand the disease characteristics and treatment outcomes of Crohn’s disease (CD) in a real-world setting in China. METHODS: In this prospective, non-interventional, multicenter disease registry, adults (≥18 years) with existing and newly diagnosed CD were recruit...
Autores principales: | Li, Yue, Chen, Baili, Gao, Xiang, Hu, Naizhong, Huang, Meifang, Ran, Zhihua, Liu, Zhanju, Zhong, Jie, Zou, Duowu, Wu, Xiaoping, Ren, Jianlin, Sheng, Jianqiu, Zheng, Ping, Wang, Huahong, Chen, Minhu, Chen, Junrong, Xi, Peng, Lu, Jiajia, Handel, Malcolm, Liu, Yanfang, Fan, Hua, Qian, Jiaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6697932/ https://www.ncbi.nlm.nih.gov/pubmed/31420025 http://dx.doi.org/10.1186/s12876-019-1057-2 |
Ejemplares similares
-
Computed tomography enterography increases the ability of endoscopy to differentiate Crohn's disease from intestinal Behçet's disease
por: Yang, Hong, et al.
Publicado: (2022) -
Differential Diagnosis of Crohn’s Disease and Ulcerative Primary Intestinal Lymphoma: A Scoring Model Based on a Multicenter Study
por: Yang, Hong, et al.
Publicado: (2022) -
Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019) -
A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021) -
Efficacy and safety of adalimumab in Chinese patients with moderately to severely active Crohn’s disease: results from a randomized trial
por: Chen, Baili, et al.
Publicado: (2020)